Institutional Ownership
Dbv Technologies S A
CUSIP 23306J309SPONSORED ADSDBVTQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
17.1%
Max % of class reported
Institutional Holders
70
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Mpm Bioimpact LLC | 13G | 9.9% | 24.58M | SEC |
| 2 | Feb 17, 2026 | Venrock Healthcare Capital Partners II, L.P. | 13G/A | — | 913.31M | SEC |
| 3 | Feb 13, 2026 | Invus Public Equities, L.P. | 13G/A | 6.2% | 14.35M | SEC |
| 4 | Feb 13, 2026 | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 5.7% | 15.69M | SEC |
| 5 | Feb 3, 2026 | Artisan Partners Asset Management Inc. | 13G | 7.0% | 3.31M | SEC |
| 6 | Jan 14, 2026 | Baker Bros. Advisors LP | 13D/A | 10.0% | — | SEC |
| 7 | Jan 7, 2026 | Bpifrance Participations S.A. | 13D/A | 4.7% | — | SEC |
| 8 | Jan 5, 2026 | Bpifrance Participations S.A. | 13D/A | 5.3% | — | SEC |
| 9 | Dec 19, 2025 | Bpifrance Participations S.A. | 13D/A | 6.8% | — | SEC |
| 10 | Nov 14, 2025 | Venrock Healthcare Capital Partners II, L.P. | 13G/A | 8.2% | 11.93M | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Dbv Technologies S A.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Mpm Bioimpact LLC | 5.21M | $108.91M |
| 2 | Vivo Capital, LLC | 2.67M | $55.73M |
| 3 | Artisan Partners Limited Partnership | 2.22M | $46.36M |
| 4 | Siren, L.L.C. | 1.86M | $38.80M |
| 5 | Baker Bros. Advisors LP | 1.46M | $30.53M |
| 6 | Adar1 Capital Management, LLC | 1.01M | $21.16M |
| 7 | Perceptive Advisors LLC | 964.4K | $20.15M |
| 8 | Patient Square Capital LP | 693.5K | $14.49M |
| 9 | Octagon Capital Advisors LP | 574.2K | $12.00M |
| 10 | Redmile Group, LLC | 491.3K | $10.26M |